Xcout Intel
Angitia Biopharmaceuticals competitors & alternatives
The 12 closest competitors and alternatives to Angitia Biopharmaceuticals among biotech companies — ranked by similarity to what Angitia Biopharmaceuticals actually does, not by market-cap band.
Subscribe to see Angitia Biopharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Angitia Biopharmaceuticals
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for serious musculoskeletal diseases.
Angitia Biopharmaceuticals at a glance
Angitia Biopharmaceuticals is a biotech company headquartered in United States. Xcout tracks 9 named people at Angitia Biopharmaceuticals, including Hua Zhu (David) Ke (Founder, Chairman, Chief Executive Officer).
Angitia Biopharmaceuticals leadership
- Hua Zhu (David) KeFounder, Chairman, Chief Executive Officer
- Willard DereChief Medical Officer, Chief Advisor to CEO
- Mike ArenbergChief Financial Officer
- Lei ZhengChief Technology Officer
- Ann ZoveinChief Scientific Officer
- Muyu (Luna) LiCo-founder, Chief Operating Officer
3 more named people on record for Angitia Biopharmaceuticals, with roles, board committees and tenure — see the full roster →
Top 12 Angitia Biopharmaceuticals competitors
Ranked by semantic similarity — how close each company is to Angitia Biopharmaceuticals by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology / Life Science
Engitix is a biotechnology company that utilizes a proprietary platform based on human Extracellular Matrix (ECM) scaffolds to model and study disease biology. The company develops discovery-stage therapeutics targeting fibrosis, inflammation, and solid tumors, and forms partnerships with pharmaceutical and biotech organizations.
Biotechnology
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Biotechnology
Augustine Therapeutics is a biotechnology company focused on developing selective HDAC6 inhibitors for the treatment of neuromuscular, neurodegenerative, and cardiometabolic diseases.
Biotechnology
Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Similar biotech company
Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins. The company focuses on creating treatments for patients with hematological and neuromuscular disorders linked to dysfunctional protein signaling.
Biotechnology
Amplicore Inc. develops injectable therapeutics aimed at treating degenerative musculoskeletal disorders such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The company focuses on regenerative and minimally invasive approaches to address the underlying causes of joint discomfort and restore mobility for patients.
Biotechnology
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Similar biotech company
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Biotechnology
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Similar biotech company
Antheia, Inc. is an advanced biotechnology research and biosynthesis company headquartered in Menlo Park, California, delivering 21st-century pharmaceutical solutions.
Biotechnology
TigaTx is a Boston-based biotechnology company founded in 2018 that is developing a pipeline of therapies targeting various cancer types and infectious diseases.
Biotechnology
Koutif Therapeutics is a biotechnology company that develops therapeutic compounds to treat inflammatory diseases by inhibiting the ubiquitin degradation pathway. The company focuses on targeting Fbxo3, an E3 ligase, to promote the degradation of pro-inflammatory proteins involved in immune signaling pathways.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Angitia Biopharmaceuticals and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Angitia Biopharmaceuticalsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →